EUVIMEDEUVIMED entdecken
Beobachtungsstudie

Real-world efficacy and safety of sonidegib in locally advanced and multiple basal cell carcinomas: a monocentric prospective observational study

Chiara Del Re, Vincenzo Filastro, Gaia Fasano, Giancarlo Valenti, Pierfrancesco De Giacomo

Clinical and Experimental Dermatology · 17.08.2026 · 51 (9) · 1699-1703

DOI: 10.1093/ced/llag157 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Clinical and Experimental Dermatology, online erschienen am 17.08.2026. Verfasst von Chiara Del Re und 4 weiteren Autor:innen. Beteiligte Einrichtung: Health Science Department, Magna Graecia University, Catanzaro, Italy. Hauptthemen laut MEDLINE: Pyridines, Basal Cell Carcinoma, Skin Neoplasms, Biphenyl Compounds. Die Arbeit nennt 9 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This monocentric study evaluated the real-world efficacy and safety of sonidegib in 17 patients with locally advanced (laBCC) or multiple (mBCC) basal cell carcinomas, characterized by complex surgical histories and comorbidities. The objective response was that 53% of patients achieved complete response, 29% partial response and 18% stable disease, with no documented progression during treatment (mean 7.3 months). Sonidegib showed significant efficacy in mBCC, with a mean reduction of 3.89 lesions per patient. Key findings indicate that prior surgery correlates with poorer response, while sonidegib effectively ‘clears the field’ of subclinical lesions. The safety profile was favourable, with predominantly mild and manageable adverse events. Despite the limited sample size, our findings confirm the significant efficacy of sonidegib in a frail pretreated population with multiple comorbidities. This study supports the use of sonidegib as a valuable therapeutic strategy for complex patients with high tumour burden or those ineligible for further surgery.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PyridinesBasal Cell CarcinomaSkin NeoplasmsBiphenyl CompoundsAntineoplastic AgentsHumansFemaleMaleProspective StudiesAgedMiddle AgedTreatment OutcomeAged, 80 and overAdult

Substanzen

PyridinessonidegibBiphenyl CompoundsAntineoplastic Agents

Autor:innen und Institutionen

  • Health Science Department, Magna Graecia University, Catanzaro, Italy.
  • Dermatology Complex Unit, Dulbecco University Hospital, Pugliese Ciaccio Hospital, Catanzaro, Italy.

Zitieren

APA

Del Re, C., Filastro, V., Fasano, G., Valenti, G., & De Giacomo, P. (2026). Real-world efficacy and safety of sonidegib in locally advanced and multiple basal cell carcinomas: a monocentric prospective observational study. Clinical and Experimental Dermatology, 51(9), 1699-1703. https://doi.org/10.1093/ced/llag157

Vancouver

Del Re C, Filastro V, Fasano G, Valenti G, De Giacomo P. Real-world efficacy and safety of sonidegib in locally advanced and multiple basal cell carcinomas: a monocentric prospective observational study. Clinical and Experimental Dermatology. 2026;51(9):1699-1703. doi:10.1093/ced/llag157

BibTeX
@article{DelRe2026,
  author = {Del Re, Chiara and Filastro, Vincenzo and Fasano, Gaia and Valenti, Giancarlo and De Giacomo, Pierfrancesco},
  title = {Real-world efficacy and safety of sonidegib in locally advanced and multiple basal cell carcinomas: a monocentric prospective observational study},
  journal = {Clinical and Experimental Dermatology},
  year = {2026},
  volume = {51},
  number = {9},
  pages = {1699--1703},
  doi = {10.1093/ced/llag157}
}
Kostenlos starten →